• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高铁蛋白血症是慢性肝病脂肪变性的一个危险因素。

Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

作者信息

Licata Anna, Nebbia Maria Elena, Cabibbo Giuseppe, Iacono Giovanna Lo, Barbaria Francesco, Brucato Virna, Alessi Nicola, Porrovecchio Salvatore, Di Marco Vito, Craxì Antonio, Cammà Calogero

机构信息

Gastroenterology and Hepatology Unit, Department of Internal Medicine, University of Palermo, 90127 Palermo, Italy.

出版信息

World J Gastroenterol. 2009 May 7;15(17):2132-8. doi: 10.3748/wjg.15.2132.

DOI:10.3748/wjg.15.2132
PMID:19418586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2678584/
Abstract

AIM

To investigate the relationship between ferritin and steatosis in patients with chronically abnormal liver function tests (LFTs) and high ferritin level.

METHODS

One hundred and twenty-four consecutive patients with hyperferritinemia (male > 300 ng/mL, female > 200 ng/mL) were evaluated; clinical, biochemical and serological data, iron status parameters, HFE gene mutations and homeostasis model assessment score were obtained. Steatosis was graded by ultrasound as absent or present. Histology was available in 53 patients only.

RESULTS

Mean level of ferritin was 881 +/- 77 ng/mL in men and 549 +/- 82 ng/mL in women. The diagnosis was chronic hepatitis C in 53 (42.7%), non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in 57 (45.9%), and cryptogenic liver damage in 14 (11.3%). None was diagnosed as hereditary hemochromatosis (HH). Hepatic siderosis on liver biopsy was present in 17 of 54 (32%) patients; grade 1 in eight and grade 2 in nine. Overall, 92 patients (74.2%) had steatosis. By logistic regression, ferritin and gamma-glutamyltransferase were independent predictors of steatosis. Ferritin levels were significantly related to low platelet count, steatosis and hepatitis C virus infection.

CONCLUSION

In a non-obese cohort of non-alcoholic patients with chronically abnormal LFTs without HH, high serum ferritin level is a risk factor for steatosis.

摘要

目的

研究肝功能长期异常且铁蛋白水平升高的患者中铁蛋白与脂肪变性之间的关系。

方法

对124例连续的高铁蛋白血症患者(男性>300 ng/mL,女性>200 ng/mL)进行评估;获取临床、生化和血清学数据、铁状态参数、HFE基因突变及稳态模型评估得分。通过超声对脂肪变性进行分级,分为无或有。仅53例患者有组织学检查结果。

结果

男性铁蛋白平均水平为881±77 ng/mL,女性为549±82 ng/mL。诊断为慢性丙型肝炎的有53例(42.7%),非酒精性脂肪性肝病/非酒精性脂肪性肝炎的有57例(45.9%),原因不明的肝损伤有14例(11.3%)。无患者被诊断为遗传性血色素沉着症(HH)。54例患者中有17例(32%)肝活检显示肝铁沉积;8例为1级,9例为2级。总体而言,92例患者(74.2%)有脂肪变性。通过逻辑回归分析,铁蛋白和γ-谷氨酰转移酶是脂肪变性的独立预测因素。铁蛋白水平与低血小板计数、脂肪变性及丙型肝炎病毒感染显著相关。

结论

在一组无HH的非肥胖非酒精性慢性肝功能异常患者中,高血清铁蛋白水平是脂肪变性的一个危险因素。

相似文献

1
Hyperferritinemia is a risk factor for steatosis in chronic liver disease.高铁蛋白血症是慢性肝病脂肪变性的一个危险因素。
World J Gastroenterol. 2009 May 7;15(17):2132-8. doi: 10.3748/wjg.15.2132.
2
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.高铁蛋白血症、铁过载和多种代谢改变可识别非酒精性脂肪性肝炎的高危患者。
Am J Gastroenterol. 2001 Aug;96(8):2448-55. doi: 10.1111/j.1572-0241.2001.04052.x.
3
Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients.血清铁蛋白水平升高与丙型肝炎病毒感染患者的肝脂肪变性和纤维化相关。
J Chin Med Assoc. 2019 Feb;82(2):99-104. doi: 10.1097/JCMA.0000000000000009.
4
Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.慢性丙型肝炎患者肝脂肪变性与铁过载相关,但与 HFE 基因突变无关。
Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):377-84. doi: 10.1016/s1499-3872(13)60059-4.
5
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.意大利南部严重肥胖的非糖尿病青年成人中的非酒精性脂肪性肝病
Ann Nutr Metab. 2005 Sep-Oct;49(5):289-95. doi: 10.1159/000087295. Epub 2005 Aug 2.
6
Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.在没有铁过载的患者中,高铁蛋白血症与胰岛素抵抗和脂肪肝有关。
PLoS One. 2008;3(10):e3547. doi: 10.1371/journal.pone.0003547. Epub 2008 Oct 28.
7
Steatosis is a cofactor in liver injury in hemochromatosis.肝脂肪变性是血色素沉着症肝损伤的一个辅助因素。
Gastroenterology. 2005 Dec;129(6):1937-43. doi: 10.1053/j.gastro.2005.09.015.
8
Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.血清铁蛋白是非酒精性脂肪性肝炎(NASH)日本患者的临床生物标志物,与 HFE 基因突变无关。
Dig Dis Sci. 2010 Mar;55(3):808-14. doi: 10.1007/s10620-009-0771-y. Epub 2009 Mar 7.
9
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.遗传性血色素沉着症基因突变、肝脏铁含量与肝纤维化:非酒精性脂肪性肝炎与C282Y的种族特异性关联,而非与纤维化严重程度的关联。
Hepatology. 2002 Jul;36(1):142-9. doi: 10.1053/jhep.2002.33892.
10
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.血清铁蛋白水平与非酒精性脂肪性肝病患者的血管损伤有关。
Nutr Metab Cardiovasc Dis. 2011 Aug;21(8):568-75. doi: 10.1016/j.numecd.2010.01.003. Epub 2010 Apr 13.

引用本文的文献

1
Expanding Pharmacists' Role in the Management of Non-Alcoholic Fatty Liver Disease.扩大药剂师在非酒精性脂肪性肝病管理中的作用。
Pharmacy (Basel). 2023 Sep 21;11(5):151. doi: 10.3390/pharmacy11050151.
2
Pearls and pitfalls in nonalcoholic fatty liver disease: tricky results are common.非酒精性脂肪性肝病的要点与陷阱:棘手的结果很常见。
Metab Target Organ Damage. 2021 Sep;1(1). doi: 10.20517/mtod.2021.02. Epub 2021 Jul 2.
3
Serum or plasma ferritin concentration as an index of iron deficiency and overload.血清或血浆铁蛋白浓度作为铁缺乏和铁过载的指标。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD011817. doi: 10.1002/14651858.CD011817.pub2.
4
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.非酒精性脂肪性肝病的病理生理学、分子和治疗问题概述。
Int J Mol Sci. 2019 Apr 20;20(8):1948. doi: 10.3390/ijms20081948.
5
Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children.白细胞介素-18 在肥胖儿童肝脂肪变性中的预测作用。
Can J Gastroenterol Hepatol. 2018 Apr 26;2018:3870454. doi: 10.1155/2018/3870454. eCollection 2018.
6
Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women.血清铁蛋白与非糖尿病男性和女性的非酒精性脂肪性肝病及β细胞功能下降有关。
J Diabetes Complications. 2014 Mar-Apr;28(2):177-84. doi: 10.1016/j.jdiacomp.2013.11.007. Epub 2013 Nov 26.
7
Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response.经皮射频消融 (RFA) 治疗的肝细胞癌 (HCC) 患者的生存受完全放射学反应的影响。
PLoS One. 2013 Jul 29;8(7):e70016. doi: 10.1371/journal.pone.0070016. Print 2013.
8
Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病:肝脏是另一个靶器官吗?
Front Neurol. 2012 Oct 17;3:149. doi: 10.3389/fneur.2012.00149. eCollection 2012.
9
Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝纤维化的无创预测指标
World J Hepatol. 2011 Aug 27;3(8):219-27. doi: 10.4254/wjh.v3.i8.219.
10
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.血清铁蛋白是非酒精性脂肪性肝病患者组织学严重程度和肝纤维化进展的独立预测因子。
Hepatology. 2012 Jan;55(1):77-85. doi: 10.1002/hep.24706. Epub 2011 Dec 6.

本文引用的文献

1
Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons.铁蛋白、代谢综合征与非酒精性脂肪性肝病:选择性吸引与危险关联
J Hepatol. 2007 Apr;46(4):549-52. doi: 10.1016/j.jhep.2007.01.004. Epub 2007 Jan 26.
2
NAFLD and hyperinsulinemia are major determinants of serum ferritin levels.非酒精性脂肪性肝病和高胰岛素血症是血清铁蛋白水平的主要决定因素。
J Hepatol. 2007 Apr;46(4):700-7. doi: 10.1016/j.jhep.2006.09.018. Epub 2006 Nov 7.
3
Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.慢性丙型肝炎患者的肝脏铁含量、肝脂肪变性及病毒基因型
J Viral Hepat. 2006 Mar;13(3):199-205. doi: 10.1111/j.1365-2893.2005.00662.x.
4
Hepatitis C and steatosis: a reappraisal.丙型肝炎与脂肪变性:重新评估
J Viral Hepat. 2006 Feb;13(2):73-80. doi: 10.1111/j.1365-2893.2005.00669.x.
5
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.在基因型1慢性丙型肝炎的非糖尿病患者中,胰岛素抵抗与脂肪变性相关。
Hepatology. 2006 Jan;43(1):64-71. doi: 10.1002/hep.20983.
6
[Aetiological spectrum of hyperferritinemia].[高铁蛋白血症的病因谱]
Rev Med Interne. 2005 May;26(5):368-73. doi: 10.1016/j.revmed.2005.01.005. Epub 2005 Feb 12.
7
Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.非酒精性脂肪性肝病患者的血红素加氧酶-1水平及氧化应激相关参数
J Hepatol. 2005 Apr;42(4):585-91. doi: 10.1016/j.jhep.2004.11.040. Epub 2005 Jan 21.
8
Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.慢性丙型肝炎患者血清铁蛋白、肝脏铁染色、糖尿病与纤维化进展之间的关系
Aliment Pharmacol Ther. 2005 Mar 1;21(5):519-24. doi: 10.1111/j.1365-2036.2005.02382.x.
9
Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection.糖尿病是慢性丙型肝炎病毒感染中检测到铁蛋白水平升高的主要因素。
Diabetes Care. 2004 Nov;27(11):2669-75. doi: 10.2337/diacare.27.11.2669.
10
Body fat distribution, relative weight, and liver enzyme levels: a population-based study.体脂分布、相对体重与肝酶水平:一项基于人群的研究。
Hepatology. 2004 Mar;39(3):754-63. doi: 10.1002/hep.20149.